Brazilian Firm Enters Market

Teuto Labs, a Brazilian drugmaker, has been granted approval to export its pharmaceuticals to Libya following certification from the Libyan Ministry of Health. BMI notes that increasing its trade partners will advance Libya's pharmaceutical sector by diversifying the selection of generic products available on the market. This development is in line with the existing Middle East trend of increasing generic drug uptake and later, domestic generic manufacture.

To read the full article, please choose one of the following options: